Log in

Satsuma Pharmaceuticals Short Interest Ratio and Short Volume

+0.07 (+1.57 %)
(As of 11/25/2020 12:00 AM ET)
Today's Range
Now: $4.54
50-Day Range
MA: $4.03
52-Week Range
Now: $4.54
Volume194,451 shs
Average Volume739,223 shs
Market Capitalization$79.10 million
P/E RatioN/A
Dividend YieldN/A

Short Interest

Satsuma Pharmaceuticals (NASDAQ:STSA) Short Interest Data

Current Short Volume:812,600 shares
Previous Short Volume:853,100 shares
Change Vs. Previous Month:-4.75%
Dollar Volume Sold Short:$3.40 million
Short Interest Ratio / Days to Cover:0.0
Last Record Date:October, 30 2020
Outstanding Shares:17,422,000 shares
Float Size:12,700,000 shares
Short Percent of Float:6.40%
Today's Trading Volume:194,451 shares
Average Trading Volume:739,223 shares
Today's Volume Vs. Average:-73.70%

Satsuma Pharmaceuticals (NASDAQ:STSA) Short Interest History

DateShares Sold ShortDollar Volume Sold ShortPercentage ChangePercentage FloatDays to CoverPrice on Record Date
10/30/2020812,600 $3.40 million -4.8%6.4%0.3$4.18
10/15/2020853,100 $3.27 million 12.9%6.7%0.4$3.83
9/30/2020755,900 $3.11 million 11.4%6.0%0.3$4.11
9/15/2020678,500 $2.77 million 141.7%5.3%0.3$4.08
8/31/2020280,700 $1.38 million 12.6%2.2%0.2$4.90
8/14/2020249,300 $5.46 million -4.0%2.0%3.2$21.92
7/31/2020259,800 $6.34 million 41.7%2.1%3.3$24.39
7/15/2020183,300 $4.33 million 18.0%1.5%2.6$23.61
6/30/2020155,300 $3.98 million 74.5%1.2%2.3$25.63
6/15/202089,000 $2.46 million 4.2%0.7%1.7$27.69
5/29/202085,400 $2.63 million 6.8%0.7%2$30.83
5/15/202080,000 $2.10 million 9.9%0.6%1.9$26.20
4/30/202072,800 $1.82 million -6.8%0.6%1.8$24.97
4/15/202078,100 $1.55 million -32.0%0.6%1.8$19.87
3/31/2020114,800 $2.09 million 27.0%0.9%2.3$18.22
3/13/202090,400 $1.64 million 13.0%0.7%2.1$18.09
2/28/202080,000 $1.36 million -8.4%0.6%1$16.98
2/14/202087,300 $2.53 million -1.9%0.7%1.1$29.01
1/31/202089,000 $2.35 million -37.1%0.7%1.1$26.38
1/15/2020141,500 $3.83 million -18.4%1.1%1.8$27.09
12/31/2019173,300 $3.41 million 0.0%1.4%2.3$19.67

Satsuma Pharmaceuticals (NASDAQ:STSA) Short Interest FAQ

speech bubbles
speech bubbles

What is Satsuma Pharmaceuticals' current short interest?

Short interest is the volume of Satsuma Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of October 30th, traders have sold 812,600 shares of STSA short. 6.40% of Satsuma Pharmaceuticals' shares are currently sold short. View details.

What is a good short interest percentage for Satsuma Pharmaceuticals?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 6.40% of Satsuma Pharmaceuticals' floating shares are currently sold short.

Is Satsuma Pharmaceuticals' short interest increasing or decreasing?

Satsuma Pharmaceuticals saw a decrease in short interest in the month of October. As of October 30th, there was short interest totaling 812,600 shares, a decrease of 4.7% from the previous total of 853,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Satsuma Pharmaceuticals' float size?

Satsuma Pharmaceuticals currently has issued a total of 17,422,000 shares. Some of Satsuma Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Satsuma Pharmaceuticals currently has a public float of 12,700,000 shares.

How does Satsuma Pharmaceuticals' short interest compare to its competitors?

6.40% of Satsuma Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the sub-industry of "regional banks" compare to Satsuma Pharmaceuticals: Truist Financial Co. (1.16%), The PNC Financial Services Group, Inc. (1.12%), First Republic Bank (0.00%), Fifth Third Bancorp (1.57%), SVB Financial Group (1.65%), KeyCorp (1.51%), M&T Bank Co. (2.12%), Regions Financial Co. (2.17%), Huntington Bancshares Incorporated (1.73%), and Commerce Bancshares, Inc. (3.47%).

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.66 billion), Aon Plc ($3.83 billion), Analog Devices, Inc. ($3.33 billion), ViacomCBS Inc. ($3.13 billion), Snap Inc. ($3.05 billion), The Clorox Company ($2.85 billion), Uber Technologies, Inc. ($2.80 billion), Moderna, Inc. ($2.26 billion), Simon Property Group, Inc. ($2.02 billion), and International Flavors & Fragrances Inc. ($1.96 billion). View all of the most shorted stocks.

What does it mean to sell short Satsuma Pharmaceuticals stock?

Short selling STSA is an investing strategy that aims to generate trading profit from Satsuma Pharmaceuticals as its price is falling. Satsuma Pharmaceuticals' stock is trading up $0.07 today. To short Satsuma Pharmaceuticals stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that Satsuma Pharmaceuticals will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Satsuma Pharmaceuticals?

A short squeeze for Satsuma Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of STSA, which in turn drives the price of the stock up even further.

How often is Satsuma Pharmaceuticals' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including STSA, twice per month. The most recent reporting period available is October, 30 2020.

This page was last updated on 11/27/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.